(Total Views: 351)
Posted On: 03/18/2020 2:06:19 PM
Post# of 9144
I'll give it a shot.
1) I think existing production facilities can manufacture the N-Assay expeditiously because it is based on ELISA which has been around a long time. At what volume will depend on who the Contractor is.
2) I don't know that susceptibility can be determined for viruses in general and COVID-19 specifically because there isn't a vaccine yet. Susceptibility in bacteria to antibiotics required additional time for the pathogen to grow in cases when the infection was most recent.
3) I think this is the lateral flow test? I believe this was a new development based on the N-Assay, but not exactly the N-Assay.
1) I think existing production facilities can manufacture the N-Assay expeditiously because it is based on ELISA which has been around a long time. At what volume will depend on who the Contractor is.
2) I don't know that susceptibility can be determined for viruses in general and COVID-19 specifically because there isn't a vaccine yet. Susceptibility in bacteria to antibiotics required additional time for the pathogen to grow in cases when the infection was most recent.
3) I think this is the lateral flow test? I believe this was a new development based on the N-Assay, but not exactly the N-Assay.
(0)
(0)
